Lukin, D., Faleck, D., Xu, R., Zhang, Y., Weiss, A., Aniwan, S., . . . Dulai, P. S. (2020). Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. Clin Gastroenterol Hepatol.
Citação norma ChicagoLukin, Dana, et al. "Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis." Clin Gastroenterol Hepatol 2020.
MLA CitationLukin, Dana, et al. "Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis." Clin Gastroenterol Hepatol 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.